Overview

Study of Loteprednol Etabonate in Adults Undergoing Bilateral Cataract Surgery

Status:
Completed
Trial end date:
2019-10-07
Target enrollment:
Participant gender:
Summary
This study will assess the bioequivalence of Loteprednol Etabonate and the reference listed drug (RLD)
Phase:
Phase 1
Details
Lead Sponsor:
Sandoz
Treatments:
Loteprednol Etabonate